{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T08:08:13Z","timestamp":1780387693456,"version":"3.54.1"},"reference-count":55,"publisher":"Oxford University Press (OUP)","issue":"Supplement_5","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001352","name":"National University of Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001352","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Asia faces significant barriers to accessing newer antibiotics despite a high burden of antimicrobial resistance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a literature review to identify key gaps and challenges in access to newer antibiotics in Asian countries. Peer-reviewed and gray literature from January 2010 to October 2024 were searched for articles discussing access to Food and Drug Administration (FDA)-approved antibiotics post-2010 with an Asian perspective. A total of 134 articles were reviewed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Key challenges spanned 7 main stakeholders: pharmaceutical industries, drug regulatory agencies, health technology assessment agencies, funders\/nongovernmental organizations, healthcare practitioners, patient advocates, and ministries of health\/policymakers. These challenges included limited and fragmented epidemiological data, insufficient health economic assessments, manufacturing constraints, complex regulatory frameworks, inefficient distribution systems, poor affordability in low-resource settings, and weak governance structures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings underscore the urgent need for a deeper understanding of stakeholder- and context-specific perspectives to address critical gaps and improve antibiotic access in the region.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cid\/ciag024","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T12:17:54Z","timestamp":1768220274000},"page":"S154-S161","source":"Crossref","is-referenced-by-count":0,"title":["Challenges to Accessing Newer Antibiotics for Multidrug-resistant Bacterial Infections in Asia: A Literature Review of Multi-Stakeholder Perspectives"],"prefix":"10.1093","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-4940-9980","authenticated-orcid":false,"given":"Alec F","family":"Aligui","sequence":"first","affiliation":[{"name":"Clinical and Translational Research Institute, The Medical City , Ortigas Avenue, Pasig City ,","place":["Philippines"]},{"name":"ADVANCE-ID, Saw Swee Hock School of Public Health, National University of Singapore ,","place":["Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanton Winter","family":"Hor","sequence":"additional","affiliation":[{"name":"ADVANCE-ID, Saw Swee Hock School of Public Health, National University of Singapore ,","place":["Singapore"]},{"name":"Antimicrobial Resistance, Clinton Health Access Initiative (CHAI) , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4344-4601","authenticated-orcid":false,"given":"Alejandro","family":"Blanco-Ar\u00e9valo","sequence":"additional","affiliation":[{"name":"ADVANCE-ID, Saw Swee Hock School of Public Health, National University of Singapore ,","place":["Singapore"]},{"name":"Infectious Diseases Department, Bellvitge University Hospital, L\u2019Hospitalet de Llobregat , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atharvi","family":"Gupta","sequence":"additional","affiliation":[{"name":"ADVANCE-ID, Saw Swee Hock School of Public Health, National University of Singapore ,","place":["Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rathi","family":"Saravanan","sequence":"additional","affiliation":[{"name":"Centre of Regulatory Excellence (CoRE), Duke-NUS Medical School ,","place":["Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Leong","sequence":"additional","affiliation":[{"name":"Centre of Regulatory Excellence (CoRE), Duke-NUS Medical School ,","place":["Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Olney","sequence":"additional","affiliation":[{"name":"Sydney Medical School, University of Sydney , Sydney, New South Wales ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7386-0031","authenticated-orcid":false,"given":"Yiyun","family":"Shou","sequence":"additional","affiliation":[{"name":"Saw Swee Hock School of Public Health, National University of Singapore and National University Health System ,","place":["Singapore"]},{"name":"Lloyd's Register Foundation Institute for the Public Understanding of Risk, National University of Singapore ,","place":["Singapore"]},{"name":"School of Medicine and Psychology, The Australian National University , Canberra, Australian Capital Territory ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia Yi","family":"Chee","sequence":"additional","affiliation":[{"name":"ADVANCE-ID, Saw Swee Hock School of Public Health, National University of Singapore ,","place":["Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2440-8548","authenticated-orcid":false,"given":"Russell","family":"Yap","sequence":"additional","affiliation":[{"name":"Saw Swee Hock School of Public Health, National University of Singapore and National University Health System ,","place":["Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shweta R","family":"Singh","sequence":"additional","affiliation":[{"name":"ADVANCE-ID, Saw Swee Hock School of Public Health, National University of Singapore ,","place":["Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0216-9550","authenticated-orcid":false,"given":"Yin","family":"Mo","sequence":"additional","affiliation":[{"name":"ADVANCE-ID, Saw Swee Hock School of Public Health, National University of Singapore ,","place":["Singapore"]},{"name":"Infectious Diseases Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore ,","place":["Singapore"]},{"name":"Mahidol-Oxford Research Unit, Mahidol University , Bangkok ,","place":["Thailand"]},{"name":"Center for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford , Oxford ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"key":"2026060203211653500_ciag024-B1","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050","volume":"404","author":"Naghavi","year":"2024","journal-title":"The Lancet"},{"key":"2026060203211653500_ciag024-B2","volume-title":"WHO Bacterial priority pathogens list 2024: bacterial pathogens of public health importance, to guide research, development, and strategies to prevent and control antimicrobial resistance","author":"World Health","year":"2024","edition":"1st ed"},{"key":"2026060203211653500_ciag024-B3","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.3390\/molecules28041762","article-title":"A comprehensive overview of the antibiotics approved in the last two decades: retrospects and prospects","volume":"28","author":"Shi","year":"2023","journal-title":"Molecules"},{"key":"2026060203211653500_ciag024-B4","doi-asserted-by":"crossref","first-page":"e0205166","DOI":"10.1371\/journal.pone.0205166","article-title":"Introduction and geographic availability of new antibiotics approved between 1999 and 2014","volume":"13","author":"K\u00e5llberg","year":"2018","journal-title":"PLoS One"},{"key":"2026060203211653500_ciag024-B5","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41579-019-0293-3","article-title":"Antibiotic development\u2014economic, regulatory and societal challenges","volume":"18","author":"\u00c5rdal","year":"2020","journal-title":"Nat Rev Microbiol"},{"key":"2026060203211653500_ciag024-B6","volume-title":"Global survey on diagnosis and management of multi-resistant gram-negative bacilli: divergence of practice between high-income countries and the rest of the world. [unpublished dissertation]","author":"Manesh","year":"2024"},{"key":"2026060203211653500_ciag024-B7","author":"Frost","year":"2019"},{"key":"2026060203211653500_ciag024-B8","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.trsl.2020.02.006","article-title":"Evaluating for-profit public benefit corporations as an additional structure for antibiotic development and commercialization","volume":"220","author":"Outterson","year":"2020","journal-title":"Transl Res"},{"key":"2026060203211653500_ciag024-B9","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s40121-021-00412-y","article-title":"Cost analysis of new antibiotics to treat multidrug-resistant bacterial infections: mind the gap","volume":"10","author":"Yahav","year":"2021","journal-title":"Infect Dis Ther"},{"key":"2026060203211653500_ciag024-B10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkad291","article-title":"Strategies to improve antibiotic access and a way forward for lower middle-income countries","volume":"79","author":"Wasan","year":"2024","journal-title":"J Antimicrob Chemother"},{"key":"2026060203211653500_ciag024-B11","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1016\/S1473-3099(19)30552-3","article-title":"(Inter)nationalising the antibiotic research and development pipeline","volume":"20","author":"Singer","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"2026060203211653500_ciag024-B12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3390\/biology12010101","article-title":"Landscape of push funding in antibiotic research: current status and way forward","volume":"12","author":"Wasan","year":"2023","journal-title":"Biology"},{"key":"2026060203211653500_ciag024-B13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1057\/s41599-024-03452-0","article-title":"Novel insights from financial analysis of the failure to commercialise plazomicin: implications for the antibiotic investment ecosystem","volume":"11","author":"Wells","year":"2024","journal-title":"Humanit Soc Sci Commun"},{"key":"2026060203211653500_ciag024-B14","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2147\/IDR.S287792","article-title":"Encouraging the development of new antibiotics: are financial incentives the right way forward? A systematic review and case study","volume":"14","author":"Dutescu","year":"2021","journal-title":"Infect Drug Resist"},{"key":"2026060203211653500_ciag024-B15","doi-asserted-by":"crossref","first-page":"114818","DOI":"10.1016\/j.socscimed.2022.114818","article-title":"Optimal subscription models to pay for antibiotics","volume":"298","author":"Barlow","year":"2022","journal-title":"Soc Sci Med"},{"key":"2026060203211653500_ciag024-B16","doi-asserted-by":"crossref","first-page":"dlac117","DOI":"10.1093\/jacamr\/dlac117","article-title":"Gaps in antimicrobial stewardship programmes in Asia: a survey of 10 countries","volume":"4","author":"Chang","year":"2022","journal-title":"JAC-Antimicrob Resist"},{"key":"2026060203211653500_ciag024-B17","first-page":"e112","article-title":"Antibiotic prescribing behavior among physicians in Asia: a multinational survey","volume":"3","author":"Wiboonchutikula","year":"2023","journal-title":"Antimicrob Steward Healthc Epidemiol ASHE"},{"key":"2026060203211653500_ciag024-B18","doi-asserted-by":"crossref","first-page":"e293","DOI":"10.1016\/S2214-109X(21)00463-0","article-title":"Global access to existing and future antimicrobials and diagnostics: antimicrobial subscription and pooled procurement","volume":"10","author":"Berman","year":"2022","journal-title":"Lancet Glob Health"},{"key":"2026060203211653500_ciag024-B19","first-page":"100705","article-title":"Challenges and opportunities for incentivising antibiotic research and development in Europe","volume":"33","author":"Anderson","year":"2023","journal-title":"Lancet Reg Health\u2014Eur"},{"key":"2026060203211653500_ciag024-B20","author":"IFPMA","year":"2018"},{"key":"2026060203211653500_ciag024-B21","author":"Boston Consulting Group & Wellcome Trust","year":"2022"},{"key":"2026060203211653500_ciag024-B22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13756-021-00931-w","article-title":"Surveillance of antimicrobial resistance in low- and middle-income countries: a scattered picture","volume":"10","author":"Iskandar","year":"2021","journal-title":"Antimicrob Resist Infect Control"},{"key":"2026060203211653500_ciag024-B23","doi-asserted-by":"crossref","first-page":"e0166515","DOI":"10.1371\/journal.pone.0166515","article-title":"Speeding access to vaccines and medicines in low- and middle-income countries: a case for change and a framework for optimized product market authorization","volume":"11","author":"Ahonkhai","year":"2016","journal-title":"PLoS One"},{"key":"2026060203211653500_ciag024-B24","author":"Access to"},{"key":"2026060203211653500_ciag024-B25","first-page":"31","article-title":"Impact of regulatory requirements on medicine registration in African countries\u2014perceptions and experiences of pharmaceutical companies in South Africa","volume":"5","author":"Narsai","year":"2012","journal-title":"South Med Rev"},{"key":"2026060203211653500_ciag024-B26","doi-asserted-by":"crossref","first-page":"101649","DOI":"10.1016\/j.cegh.2024.101649","article-title":"Drug regulatory harmonization in the association of Southeast Asian nations: is it time for an ASEAN medicines agency? A policy review","volume":"28","author":"Feng","year":"2024","journal-title":"Clin Epidemiol Glob Health"},{"key":"2026060203211653500_ciag024-B27","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.3390\/ph16111615","article-title":"Origin of antibiotics and antibiotic resistance, and their impacts on drug development. A narrative review","volume":"16","author":"Muteeb","year":"2023","journal-title":"Pharmaceuticals"},{"key":"2026060203211653500_ciag024-B28","doi-asserted-by":"crossref","first-page":"e012332","DOI":"10.1136\/bmjopen-2016-012332","article-title":"Health research capacity development in low and middle income countries: reality or rhetoric? A systematic meta-narrative review of the qualitative literature","volume":"7","author":"Franzen","year":"2017","journal-title":"BMJ Open"},{"key":"2026060203211653500_ciag024-B29","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s43441-022-00415-y","article-title":"A systematic review of pharmacovigilance systems in developing countries using the WHO pharmacovigilance indicators","volume":"56","author":"Garashi","year":"2022","journal-title":"Ther Innov Regul Sci"},{"key":"2026060203211653500_ciag024-B30","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s43856-024-00594-9","article-title":"Antimicrobial drug pricing","volume":"4","author":"Pandey","year":"2024","journal-title":"Commun Med"},{"key":"2026060203211653500_ciag024-B31","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.sapharm.2019.12.009","article-title":"Access to medicines\u2014a systematic review of the literature","volume":"16","author":"Abbas","year":"2020","journal-title":"Res Soc Adm Pharm RSAP"},{"key":"2026060203211653500_ciag024-B32","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jval.2016.10.014","article-title":"Health technology assessment (HTA) case studies: factors influencing divergent HTA reimbursement recommendations in Australia, Canada, England, and Scotland","volume":"20","author":"Allen","year":"2017","journal-title":"Value Health J Int Soc Pharmacoeconomics Outcomes Res"},{"key":"2026060203211653500_ciag024-B33","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/clpt.2009.261","article-title":"Medicines regulation and health technology assessment","volume":"87","author":"Breckenridge","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"2026060203211653500_ciag024-B34","doi-asserted-by":"crossref","first-page":"582634","DOI":"10.3389\/fmed.2020.582634","article-title":"Improving interactions between health technology assessment bodies and regulatory agencies: a systematic review and cross-sectional survey on processes, progress, outcomes, and challenges","volume":"7","author":"Ofori-Asenso","year":"2020","journal-title":"Front Med"},{"key":"2026060203211653500_ciag024-B35","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1093\/cid\/ciab887","article-title":"A nonprofit drug development model is part of the antimicrobial resistance (AMR) solution","volume":"74","author":"Piddock","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2026060203211653500_ciag024-B36","author":"Auld"},{"key":"2026060203211653500_ciag024-B37","author":"Global AMR"},{"key":"2026060203211653500_ciag024-B38","doi-asserted-by":"crossref","first-page":"e625","DOI":"10.1016\/S2214-109X(22)00091-2","article-title":"Antimicrobial subscription and pooled procurement","volume":"10","author":"Mohapatra","year":"2022","journal-title":"Lancet Glob Health"},{"key":"2026060203211653500_ciag024-B39","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1089\/hs.2014.0081","article-title":"Public funding of clinical-stage antibiotic development in the United States and European union","volume":"13","author":"Eichberg","year":"2015","journal-title":"Health Secur"},{"key":"2026060203211653500_ciag024-B40","doi-asserted-by":"crossref","first-page":"e70005","DOI":"10.1002\/puh2.70005","article-title":"A landscaping assessment and call-to-action to improve access to novel reserve antibiotics in 14 low- and middle-income countries","volume":"3","author":"Motta","year":"2024","journal-title":"Public Health Chall"},{"key":"2026060203211653500_ciag024-B41","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jgar.2021.01.013","article-title":"Antimicrobial stewardship capacity and manpower needs in the Asia Pacific","volume":"24","author":"Lee","year":"2021","journal-title":"J Glob Antimicrob Resist"},{"key":"2026060203211653500_ciag024-B42","doi-asserted-by":"crossref","first-page":"dlad062","DOI":"10.1093\/jacamr\/dlad062","article-title":"Drivers of inappropriate antibiotic use in low- and middle-income countries","volume":"5","author":"Otaigbe","year":"2023","journal-title":"JAC-Antimicrob Resist"},{"key":"2026060203211653500_ciag024-B43","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jiph.2023.10.043","article-title":"Potential role of civil society organizations (CSOs) in antimicrobial resistance (AMR) mitigation efforts in low- and middle-income countries: a report from India","volume":"16","author":"Ranganathan","year":"2023","journal-title":"J Infect Public Health"},{"key":"2026060203211653500_ciag024-B44","author":"ReAct"},{"key":"2026060203211653500_ciag024-B45","author":"World"},{"key":"2026060203211653500_ciag024-B46","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2471\/BLT.19.241349","article-title":"Measuring antibiotic availability and use in 20 low- and middle-income countries","volume":"98","author":"Knowles","year":"2020","journal-title":"Bull World Health Organ"},{"key":"2026060203211653500_ciag024-B47","doi-asserted-by":"crossref","first-page":"58","DOI":"10.12688\/wellcomeopenres.11985.1","article-title":"Community-level antibiotic access and use (ABACUS) in low- and middle-income countries: finding targets for social interventions to improve appropriate antimicrobial use\u2014an observational multi-centre study [version 1; peer review: 2 approved]","volume":"2","author":"Wertheim","year":"2017","journal-title":"Wellcome Open Res"},{"key":"2026060203211653500_ciag024-B48","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1478-4505-11-36","article-title":"Promoting universal financial protection: evidence from seven low- and middle-income countries on factors facilitating or hindering progress","volume":"11","author":"McIntyre","year":"2013","journal-title":"Health Res Policy Syst"},{"key":"2026060203211653500_ciag024-B49","doi-asserted-by":"crossref","first-page":"e1003139","DOI":"10.1371\/journal.pmed.1003139","article-title":"Antibiotic prescription practices in primary care in low- and middle-income countries: a systematic review and meta-analysis","volume":"17","author":"Sulis","year":"2020","journal-title":"PLoS Med"},{"key":"2026060203211653500_ciag024-B50","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12992-020-00639-3","article-title":"The global governance of antimicrobial resistance: a cross-country study of alignment between the global action plan and national action plans","volume":"16","author":"Munkholm","year":"2020","journal-title":"Global Health"},{"key":"2026060203211653500_ciag024-B51","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.cmi.2021.07.027","article-title":"Clinical microbiology laboratories in low-resource settings, it is not only about equipment and reagents, but also good governance for sustainability","volume":"27","author":"Wertheim","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"2026060203211653500_ciag024-B52","doi-asserted-by":"crossref","first-page":"e466","DOI":"10.1016\/S2214-109X(23)00019-0","article-title":"An analysis of existing national action plans for antimicrobial resistance-gaps and opportunities in strategies optimising antibiotic use in human populations","volume":"11","author":"Charani","year":"2023","journal-title":"Lancet Glob Health"},{"key":"2026060203211653500_ciag024-B53","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.3390\/antibiotics12081322","article-title":"A qualitative study on the policy process and development of the national action plan on antimicrobial resistance in Singapore","volume":"12","author":"Chua","year":"2023","journal-title":"Antibiotics"},{"key":"2026060203211653500_ciag024-B54","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/03009734.2014.912700","article-title":"Securing access to effective antibiotics for current and future generations. Whose responsibility?","volume":"119","author":"Cars","year":"2014","journal-title":"Ups J Med Sci"},{"key":"2026060203211653500_ciag024-B55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.00042-16","article-title":"Carbapenem-resistant Acinetobacter baumannii and Enterobacteriaceae in south and Southeast Asia","volume":"30","author":"Hsu","year":"2017","journal-title":"Clin Microbiol Rev"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/82\/Supplement_5\/S154\/68447043\/ciag024.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/82\/Supplement_5\/S154\/68447043\/ciag024.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T07:21:35Z","timestamp":1780384895000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/82\/Supplement_5\/S154\/8699687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":55,"journal-issue":{"issue":"Supplement_5","published-online":{"date-parts":[[2026,6,2]]},"published-print":{"date-parts":[[2026,6,2]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciag024","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6,15]]},"published":{"date-parts":[[2026,6,2]]}}}